Supplier News Breaks Archives
Pernix names senior VP of sales, marketing
March 18th, 2014
HOUSTON – Rick Shalaby has joined Pernix Therapeutics Holdings Inc. as senior vice president of sales and marketing.
The specialty pharmaceutical company said Tuesday that Shalaby brings over 23 years of pharmaceutical industry experience, including 10 in executive leadership posts.
Shalaby's career includes 18 years oat Merck & Co. Inc., where he held a variety of positions in analytics, operations, market research, marketing and managed care before taking on senior-level positions in sales, in which he managed over 200 sales professionals in specialty and primary care sales.
From Merck, he moved on to PDI and in his tenure as vice president of sales was responsible for sales operations and the leadership of over eight sales teams consisting of over s750 sales professionals. After PDI, he joined Amarin Pharmaceuticals, where he was vice president of sales and led a 300-person sales force to launch Amarin's first commercial brand.
Shalaby has also been on numerous advisory boards and is on the board of directors of Poly-Med Inc.
"Rick's deep experience combined with his motivational style and high energy levels make him the ideal candidate to take our Pernix sales and marketing efforts to the next level as we launch Khedezla in April and plan for the relaunch of Silenor shortly thereafter," stated Doug Drysdale, president and chief executive officer of Pernix. "The management team and I are excited to have Rick on board and look forward to working with him to execute the new growth strategy for Pernix."